Anna Rosell Novel Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory. Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Anna Rosell Novel Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.
As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).
Projects Grup de Recerca en Malalties Neurovasculars IP: Joan Montaner Villalonga Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 46800 Reference: 2009 SGR 432 Duration: 01/01/2010 - 30/04/2014 European Stroke Research Network (EUSTROKE) Grant Agreement Nº 202213 IP: Joan Montaner Villalonga Collaborators: José Alvarez Sabin, Maria Mar Hernandez Guillamon, Carlos Molina Cateriano, Anna Rosell Novel Funding agency: EUROPEAN COMMISSION Funding: 463200 Reference: EUSTROKE_FP7HEALTH2007 Duration: 01/03/2008 - 31/08/2013 RENEVAS - Red de Investigación Cooperativa Neurovascular IP: Joan Montaner Villalonga Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque Funding agency: Instituto de Salud Carlos III Funding: 793573.69 Reference: RD06/0026/0010 Duration: 02/01/2007 - 31/12/2013 Geno-tPA: búsqueda de patrones genéticos predictivos de la evolución del paciente con ictus isquémico después del tratamiento con t-PA IP: Joan Montaner Villalonga Collaborators: Anna Penalba Morenilla, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque Funding agency: Fundación Invest. Médica Mutua Madrileña Funding: 25000 Reference: FMMA/04/2005 Duration: 23/06/2006 - 22/06/2009 Pagination First page « Previous page ‹ … Page 5 Page 6 Page 7 Current page 8 Page 9 Next page › Last page »
